Voyageur Pharmaceuticals Ltd.

Business Description

Voyageur Pharmaceuticals Ltd., holder of three barium projects in B.C., including one with a resource estimate, and iodine properties in Utah, has a Joint Venture with privately held Chief Medical Supplies Ltd. (a Canadian pharmaceutical manufacturing and distribution company) to manufacture and market contrast agents (made with barium and/or iodine compounds) used for radiology digital imaging in the healthcare industry.

Website: https://voyageurpharmaceuticals.ca/

FRC Analyst's Reports

Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior Resource Company Building a Fully Integrated Pharmaceutical Company	Jan. 7, 2020

News

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Two New License Approvals from Health Canada for its MultiX Barium Sulfate Powder Covering Oral and Rectal Applications – Video Available on Investmentpitch.com	Apr. 7, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Receipt of Approval from Health Canada for Two of the Company’s Barium Contrast Products – Video Available on Investmentpitch.com	Feb. 17, 2021
Should You Take Comfort From Insider Transactions At Voyageur Pharmaceuticals Ltd. (CVE:VM)?	Dec. 4, 2020
Read This Before Selling Voyageur Pharmaceuticals Ltd. (CVE:VM) Shares	Jun. 7, 2020
Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Drug Development	May. 11, 2020

This company was mentioned in the following "Analysts’ Ideas Of The Week":